Literature DB >> 9528771

Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression.

M H Kaplan1, C Daniel, U Schindler, M J Grusby.   

Abstract

The proliferation of lymphocytes in response to cytokine stimulation is essential for a variety of immune responses. Recent studies with signal transducer and activator of transcription 6 (Stat6)-deficient mice have demonstrated that this protein is required for the normal proliferation of lymphocytes in response to interleukin-4 (IL-4). In this report, we show that the impaired IL-4-induced proliferative response of Stat6-deficient lymphocytes is not due to an inability to activate alternate signaling pathways, such as those involving insulin receptor substrates, or to a failure to upregulate IL-4 receptor levels. Cell cycle analysis showed that the percentage of Stat6-deficient lymphocytes that transit from the G1 to the S phase of the cell cycle following IL-4 stimulation is lower than that of control lymphocytes. Although the regulation of many genes involved in the control of cytokine-induced proliferation is normal in Stat6-deficient lymphocytes, protein levels of the cdk inhibitor p27Kip1 were found to be markedly dysregulated. p27Kip1 is expressed at significantly higher levels in Stat6-deficient lymphocytes than in control cells following IL-4 stimulation. The higher level of p27Kip1 expression seen in IL-4-stimulated Stat6-deficient lymphocytes correlates with decreased cdk2-associated kinase activity and is the result of the increased accumulation of protein rather than altered mRNA expression. Similarly, higher levels of p27Kip1 protein expression are also seen following IL-12 stimulation of Stat4-deficient lymphocytes than are seen following stimulation of control cells. These data suggest that Stat proteins may control the cytokine-induced proliferative response of activated T cells by regulating the expression of cell cycle inhibitors so that cyclin-cdk complexes may function to promote transition from the G1 to the S phase of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9528771      PMCID: PMC121429          DOI: 10.1128/MCB.18.4.1996

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  67 in total

1.  Stat6 is required for mediating responses to IL-4 and for development of Th2 cells.

Authors:  M H Kaplan; U Schindler; S T Smiley; M J Grusby
Journal:  Immunity       Date:  1996-03       Impact factor: 31.745

2.  Suppression of interleukin-3-induced gene expression by a C-terminal truncated Stat5: role of Stat5 in proliferation.

Authors:  A L Mui; H Wakao; T Kinoshita; T Kitamura; A Miyajima
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

3.  An interleukin-4-induced transcription factor: IL-4 Stat.

Authors:  J Hou; U Schindler; W J Henzel; T C Ho; M Brasseur; S L McKnight
Journal:  Science       Date:  1994-09-16       Impact factor: 47.728

4.  Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin.

Authors:  J Nourse; E Firpo; W M Flanagan; S Coats; K Polyak; M H Lee; J Massague; G R Crabtree; J M Roberts
Journal:  Nature       Date:  1994-12-08       Impact factor: 49.962

5.  Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits.

Authors:  T Miyazaki; A Kawahara; H Fujii; Y Nakagawa; Y Minami; Z J Liu; I Oishi; O Silvennoinen; B A Witthuhn; J N Ihle
Journal:  Science       Date:  1994-11-11       Impact factor: 47.728

6.  Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID.

Authors:  S M Russell; J A Johnston; M Noguchi; M Kawamura; C M Bacon; M Friedmann; M Berg; D W McVicar; B A Witthuhn; O Silvennoinen
Journal:  Science       Date:  1994-11-11       Impact factor: 47.728

7.  Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1.

Authors:  Y E Chin; M Kitagawa; W C Su; Z H You; Y Iwamoto; X Y Fu
Journal:  Science       Date:  1996-05-03       Impact factor: 47.728

8.  Association between GRB2/Sos and insulin receptor substrate 1 is not sufficient for activation of extracellular signal-regulated kinases by interleukin-4: implications for Ras activation by insulin.

Authors:  W Pruett; Y Yuan; E Rose; A G Batzer; N Harada; E Y Skolnik
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

9.  p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells.

Authors:  S B Parker; G Eichele; P Zhang; A Rawls; A T Sands; A Bradley; E N Olson; J W Harper; S J Elledge
Journal:  Science       Date:  1995-02-17       Impact factor: 47.728

10.  Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15.

Authors:  J G Giri; M Ahdieh; J Eisenman; K Shanebeck; K Grabstein; S Kumaki; A Namen; L S Park; D Cosman; D Anderson
Journal:  EMBO J       Date:  1994-06-15       Impact factor: 11.598

View more
  25 in total

Review 1.  JAK-STAT signaling in asthma.

Authors:  Alessandra B Pernis; Paul B Rothman
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

2.  SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)-->S progression by controlling the expression and cellular compartmentalization of cyclin D.

Authors:  X Lin; P Nelson; I H Gelman
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

3.  Antigen-specific dose-dependent system for the study of an inheritable and reversible phenotype in mouse CD4+ T cells.

Authors:  Eduardo J Firpo; Raymond K Kong; Qinghong Zhou; Alexander Y Rudensky; James M Roberts; B Robert Franza
Journal:  Immunology       Date:  2002-12       Impact factor: 7.397

4.  STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition.

Authors:  T Fukada; T Ohtani; Y Yoshida; T Shirogane; K Nishida; K Nakajima; M Hibi; T Hirano
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

5.  Suppressive effect of Chinese medicinal herb, Acanthopanax gracilistylus, extract on human lymphocytes in vitro.

Authors:  B E Shan; Y Yoshita; T Sugiura; U Yamashita
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

Review 6.  Transcriptional regulation by STAT6.

Authors:  Shreevrat Goenka; Mark H Kaplan
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

7.  Stat6 and IRS-2 cooperate in interleukin 4 (IL-4)-induced proliferation and differentiation but are dispensable for IL-4-dependent rescue from apoptosis.

Authors:  Andrea L Wurster; Dominic J Withers; Tohru Uchida; Morris F White; Michael J Grusby
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

8.  JAK3/STAT5/6 pathway alterations are associated with immune deviation in CD8 T cells in renal cell carcinoma patients.

Authors:  Elisabetta Cavalcanti; Margherita Gigante; Vito Mancini; Michele Battaglia; Pasquale Ditonno; Carmela Capobianco; Raffaele I Cincione; Francesco P Selvaggi; Wolfgang Herr; Walter J Storkus; Loreto Gesualdo; Elena Ranieri
Journal:  J Biomed Biotechnol       Date:  2010-03-22

9.  Endogenous suppression of mast cell development and survival by IL-4 and IL-10.

Authors:  Kelly Speiran; Daniel P Bailey; Josephine Fernando; Matthew Macey; Brian Barnstein; Motunrayo Kolawole; Dana Curley; Stephanie S Watowich; Peter J Murray; Carole Oskeritzian; John J Ryan
Journal:  J Leukoc Biol       Date:  2009-02-19       Impact factor: 4.962

10.  src homology 2 domain-containing tyrosine phosphatase SHP-1 controls the development of allergic airway inflammation.

Authors:  Tohru Kamata; Masakatsu Yamashita; Motoko Kimura; Kaoru Murata; Masamichi Inami; Chiori Shimizu; Kaoru Sugaya; Chrong-Reen Wang; Masaru Taniguchi; Toshinori Nakayama
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.